Designed for anti-amyloid beta efficacy studies, the CNS-3D Induced Alzheimer’s Model helps researchers assess whether drug candidates reduce amyloid-driven cellular, inflammatory, molecular, and functional changes.

By standardizing disease induction, it reduces the burden of model development so teams can focus on evaluating candidate efficacy. For teams that want full study execution and analysis, the same workflow is also available through CNS Services.